EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides

Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review

(2017) Jochem van der Pol et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer

(2017) Thorsten D. Poeppel et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Role of Radiation Therapy in Palliative Care of the Patient With Cancer

(2014) Stephen T. Lutz et al.   JOURNAL OF CLINICAL ONCOLOGY

Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases

(2013) Sadamoto Zenda et al.   International Journal of Clinical Oncology

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial

(2013) Ethan Basch et al.   LANCET ONCOLOGY

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

(2013) C. Parker et al.   NEW ENGLAND JOURNAL OF MEDICINE

EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy

(2012) Shinji Kurosaka et al.   ANNALS OF NUCLEAR MEDICINE

A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer

(2012) S. Nilsson et al.   EUROPEAN JOURNAL OF CANCER

Bisphosphonates in oncology

(2011) Robert E. Coleman et al.   BONE

Radionuclide treatment of painful bone metastases in patients with breast cancer: A systematic review

(2011) Mette H. Christensen et al.   CANCER TREATMENT REVIEWS

EANM procedure guideline for treatment of refractory metastatic bone pain

(2008) Lisa Bodei et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING